Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

InspireMD (NSPR) Gross Margin (2016 - 2025)

InspireMD filings provide 16 years of Gross Margin readings, the most recent being 37.47% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 1341.0% to 37.47% in Q4 2025 year-over-year; TTM through Dec 2025 was 29.5%, a 802.0% increase, with the full-year FY2025 number at 29.5%, up 802.0% from a year prior.
  • Gross Margin hit 37.47% in Q4 2025 for InspireMD, up from 34.24% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 37.47% in Q4 2025 to a low of 8.59% in Q3 2021.
  • Median Gross Margin over the past 5 years was 23.47% (2024), compared with a mean of 22.97%.
  • The widest YoY moves for Gross Margin: up 26814bps in 2021, down -2182bps in 2021.
  • InspireMD's Gross Margin stood at 21.3% in 2021, then fell by -9bps to 19.3% in 2022, then surged by 49bps to 28.68% in 2023, then decreased by -16bps to 24.06% in 2024, then skyrocketed by 56bps to 37.47% in 2025.
  • The last three reported values for Gross Margin were 37.47% (Q4 2025), 34.24% (Q3 2025), and 17.6% (Q2 2025) per Business Quant data.